sirakoss
-
Biologics
SIRAKOSS Receives U.S. FDA 510(k) Clearance for Osteo3 ZP Putty to Catalyse Rapid and Complete Bone Regeneration
Aberdeen, UK, 17 June 2020 – SIRAKOSS Ltd, a developer of nanosynthetic bone graft substitutes, announced today that it has received…
Read More » -
Hospitals
UK based medical device company announces two new patents granted by the US Patent and Trademark Office
SIRAKOSS Ltd., a UK-based medical device company developing innovative bone grafting solutions for the $3 billion global orthopaedic market, has…
Read More » -
Biologics
Scottish synthetic Bone Graft company secures $4.8m funding
SIRAKOSS, an innovative medical device company based in Edinburgh and Aberdeen today announced it has secured $4.8m (£3.1m) in Series-A…
Read More »